Trial intelligence / Profile preview

Palonosetron versus aprepitant for prevention of postoperative nausea and vomiting after laparoscopic gynecologic surgery

ACTRN12613000902796Phase 4Completed

Sponsor
Chung-Ang University
Start
Oct 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of palonosetron and aprepitant in postoperative nausea and vomiting (PONV), sponsored by Chung-Ang University. Started Oct 2011; status: completed.

02

Drugs

palonosetronaprepitant
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on ACTRN12613000902796.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12613000902796.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call